Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Payables (2016 - 2025)

Historic Payables for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to $8.5 million.

  • Orthopediatrics' Payables fell 2728.6% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year decrease of 2728.6%. This contributed to the annual value of $10.3 million for FY2024, which is 1827.02% down from last year.
  • Orthopediatrics' Payables amounted to $8.5 million in Q3 2025, which was down 2728.6% from $12.7 million recorded in Q2 2025.
  • Orthopediatrics' 5-year Payables high stood at $22.6 million for Q3 2023, and its period low was $8.5 million during Q3 2025.
  • Its 5-year average for Payables is $13.6 million, with a median of $12.6 million in 2023.
  • In the last 5 years, Orthopediatrics' Payables soared by 10758.2% in 2023 and then tumbled by 4843.49% in 2024.
  • Orthopediatrics' Payables (Quarter) stood at $9.3 million in 2021, then increased by 19.57% to $11.2 million in 2022, then rose by 13.44% to $12.6 million in 2023, then fell by 18.27% to $10.3 million in 2024, then fell by 18.08% to $8.5 million in 2025.
  • Its Payables was $8.5 million in Q3 2025, compared to $12.7 million in Q2 2025 and $14.2 million in Q1 2025.